Abstract
Background
Isoflavones present in soybean may contribute to soy atheroprotectective effects.
Aim of the study
To investigate the effect of soy isoflavones supplementation on the formation of electronegative LDL (LDL−) and its autoantibodies in blood plasma and aortic atheromas of rabbits fed an atherogenic casein-based diet enriched with isoflavones.
Methods
New Zealand male rabbits (n = 15) were fed an atherogenic diet (27% casein) supplemented with isoflavones (0.73 or 7.3 mg of isoflavones/kg/day, Low and High Iso groups, respectively) for 180 days. Monthly, blood samples were collected after 12–15 h fasting and at 180 days of treatment all animals were sacrificed. Isoflavones were analyzed in plasma and urine samples by HPLC. LDL− in plasma and atheromas was detected by ELISA and immunohistochemistry, respectively, with a monoclonal antibody reactive to LDL−. Autoantibodies reactive to LDL− were analyzed in plasma and aorta by ELISA.
Results
Low and High Iso groups had decreased LDL-cholesterol, increased HDL-cholesterol and lower levels of LDL− in blood plasma and aortic atherosclerotic lesions than the non-supplemented Control group. IgG autoantibodies reactive to LDL− were higher in plasma of the Control group in comparison with the High and Low Iso groups. In contrast, the aortas from animals that consumed isoflavones showed higher levels of IgG reactive to LDL− than the Control group.
Conclusion
Soy isoflavones showed hypolipidemic effects and decreased the pro-inflammatory LDL− subfraction in blood plasma and aorta of hypercholesterolemic rabbits.
Similar content being viewed by others
References
Davies J, Rudd J, Weisberg P (2004) Molecular and metabolic imaging of atherosclerosis. J Nuclear Med 45(11):1898–1907
Ramaa C, Shirode A, Mundada A, Kadam V (2006) Nutraceuticals – an emerging era in the treatment and prevention of cardiovascular diseases. Curr Pharm Biotechnol 7(1):15–23
Zhan S, Ho S (2005) Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am J Clin Nutr 81:397–408
Arteaga E, Villaseca P, Rojas A, Marshall G, Bianchi M (2004) Phytoestrogen possess a weak antioxidant activity on low density lipoprotein in contrast to the flavonoid quercetin in vitro in postmenopausal women. Climateric 7(4):397–403
Clarkson T (2002) Soy, soy phytoestrogens and cardiovascular disease. J Nutr 132:566S–569S
Weggemans R, Trautwein E (2003) Relation between soy-associated isoflavones and LDL and HDL cholesterol concentrations in human: a meta-analysis. Euro J Clin Nut 57:940–946
Mitchell J,Gardner P, McPhail D, Morrice P, Collins A, Duthie G (1998) Antioxidant efficacy of phytoestrogens in chemical and biological model system. Arch Biochem Biophys 360:142–148
Lee C, Kwon S, Na S, Lim S, Lee J (2004) Genistein supplementation inhibits atherosclerosis with stabilization of the lesions in hypercholesterolemic rabbits. J Korean Med Sci 19:656–661
Christian RC, Liu PY, Harrington S, Ruan M, Miller VM, Fitzpatrick LA (2006) Intimal estrogen receptor ER(β), but nor ERα expression, is correlated with coronary calcification and atherosclerosis in pre- and postmenopausal women. J Clin Endocrinol Metab 91:2718–2720
Setchell K (1998) Phytoestrogens: The biochemistry, physiology and implications for human health of soy isoflavones. Am J Clin Nutr 68(6):1333–1346
Anthony M, Clarkson T, Bullock B, Wagner J (1997) Soy protein versus soy phytoestrogens in the prevention of diet-induced coronary artery atherosclerosis of male cynomolgus monkeys. Arterioscler Thromb Vasc Biol 17: 2524–2531
Patel R, Boersman B, Crawfor J, Hogg N, Kirk M, Kalyanamara B, Parks D, Barnes S, Darley-Usmar V (2001) Antioxidant mechanisms of isoflavones in lipid system: Paradoxical effects of peroxyl radical. Free Radic Biol Med 31:1570–1581
Kerry N, Abbey M (1998) The isoflavone genistein inhibits copper and peroxyl radical mediated low density lipoprotein oxidation in vitro. Atherosclerosis 140(2):341–347
Turner R, Baron T, Wolffram S, Minihane A, Cassidy A, Rimbach G, Weinberg P (2004) Effect of circulating forms of soy isoflavones on the oxidation of low density lipoprotein. Free Radic Res 38(2):209–216
Tinahones F, Gómez-Zumaquero J, Garrido-Sánchez L, García-Fuentes E, Rojo-Martínez G, Esteva I, Adana M, Cardona F, Soriguer F (2005) Influence of age and sex on levels of anti-oxidized LDL antibodies and anti-LDL immune complexes in the general population. J Lipid Res 46:452–457
Ziouzenkova O, Sevanian A (2000) Oxidative modification of low density lipoprotein (LDL) in HD patients: role in electronegative LDL formation. Blood Purif 18(3):169–176
Sánchez-Quesada J, Benítez S, Ordóñez-Llanos J (2004) Electronagative low density lipoprotein. Curr Opin Lipidol 15:329–335
Sevanian A, Asatryan L, Ziouzenkova O (1999) Low density lipoprotein (LDL) modification: basic concepts and relationship to atherosclerosis. Blood Purif 17:66–78
Association of Official Analytical Chemistry: Official methods of analysis ed 13 Washington, AOAC, 1980
Franke A, Custer l, Tanaka Y (1998) Isoflavones in human breast milk and other biological fluids. Am J Clin Nutr 68:1466–1473
Coward L, Barnes N, Setchell K, Barnes S (1993) Genistein, daidzein and their β-glycoside conjugates: antimour isoflavones in soybean foods from american and asian diets. J Agric Food Chem 41:1961–1967
Wang H, Murphy P (1996) Mass balance study of isoflavones during soybean processing. J Agric Food Chem 44:2377–2383
Setchell K, Welsh M, Lim C (1987) HPLC analysis of phytoestrogens in soy protein preparation with ultraviolet, electrochemical and thermospray mass spectrometric detection. J Chromatogr 385:267–274
Damasceno N, Rodrigues F, Gidlund M, Goto H, Dias C, Abdalla D (2001) Casein and soy protein isolate in experimental atherosclerosis: Influence on hypercholesterolemia and lipoprotein oxidation. Ann Nutr Metab 45:38–46
Lowry O, Rosebrough N, Farr A, Randall R (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193(1):265–275
Damasceno N, Sevanian A, Apolinário E, Oliveira J, Fernandes I, Abdalla D (2006) Detection of electronegative low density lipoprotein (LDL−) in plasma and atherosclerotic lesions by monoclonal antibody-based immunoassays. Clinical Biochemistry 39:28–38
Barros M, Bertolami M, Abdalla D, Ferreira W (2006) Identification of mildly oxidized low density lipoprotein (electronegative LDL) and its auto-antibodies IgG in children and adolescents hypercholesterolemic offsprings. Atherosclerosis 184(1):103–107
Yla-Herttuala S, Jaakkola O, Ehnholm C, Tikkanem M, Solakivi T, Sarkioja T, Nikkari T (1988) Characterization of two lipoproteins containing apolipoprotein B and E from lesion-free human aortic intima. J Lipid Res 29:563–572
Owens G, Burgoon M, Devlin M, Gilden D (1997) Extraction and purification of active IgG from SSPE and MS brain. J Virol Methods 68:119–125
Kawakami Y, Tsurugasaki W, Nakamura S, Osada K (2005) Comparison of regulative functions between dietary soy isoflavones aglycone and glucoside on lipid metabolism in rats fed cholesterol. J Nutr Biochem 16:205–212
Song T, Lee S-O, Murphy P, Hendrich S (2003) Soy protein with or without isoflavones, soy germ extract, and daidzein lessen plasma cholesterol level in golden Syrian hamsters. Exp Biol Med 228:1063–1068
Geaves K, Parks J, Williams J, Wagner J (1999) Intact dietary sou protein, but not adding an isoflavones-rich soy extract to casein, improves plasma lipids in ovariectomized cynomolgus monkeys. J Nutr 129:1585–1592
Wang Y, Jones P, Ausman L, Lichtenstein A (2001) Soy protein reduces triglycerides levels and triglyceride fatty acid fractional synthesis rate in hypercholesterolemic subjects. Atherosclerosis 173(2):269–275
Anderson J, Johnstone B, Cook-Newell M (1995) Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 333:276–282
Mezei O, Chou C, Kennedy K, Tovar-Palacio C, Shay N (2002) Hepatic cytochrome p450–2A and phosphoribosylpyrophosphate synthetase associated protein mRNA are induced in gerbils after consumption of isoflavone-containing protein. J Nutr 132:2538–2544
Nogowski L, Mackowiak P, Kandulska K, Szkudelski T, Nowak K (1998) Genistein-induced changes in lipid metabolism of ovariectomized rats. Ann Nutr Metab 42:360–366
Baum J, Teng H, Erdman J (1998) Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low density lipoprotein receptor messenger RNA in hypercholesterolemic, postmenopausal women. Am J Clin Nutr 68:545–551
Jenkins D, Kendall C, Garsetti M, et al. (2000) Effect of soy protein on low density lipoprotein oxidation and ex vivo sex hormone receptor activity – a controlled crossover trial. Metabolism 49:537–43
Wiseman H, O’Reilly J, Adlercreutz H, Mallet A, Bowey E, Rowland I, Sanders T (2000) Isoflavones Phytoestrogens consumed in soy decrease F2-isoprostane concentrations and increase resistance of low density lipoprotein to oxidation in humans. Am J Clin Nutr 72:395–400
Samman S, Wall P, Chan G, Smith S, Petocz P (1999) The effect of supplementation with isoflavones on plasma lipids and oxidizability of low density lipoprotein in premenopausal women. Atherosclerosis 147:277–283
Eldrigde A (1982) High performance liquid chromatography separation of soybean isoflavones and their glucosides. J Chromatography 234:494–496
Wang H, Murphy P (1994) Isoflavones content in commercial soybean foods. J Agric Food Chem 44:2377–2383
Subbiah M, Sprinkle J, Rymaszewski Z, Yunker R (1989) Short-term exposure to high dietary cholesterol in early life: arterial changes and response after normalization of plasma cholesterol. Am J Clin Nutr 50:68–72
Shaw P, Binder C, Chang M, Hartvigsen K, Horkko S, Miller Y, Woelkers D, Corr M, Witztum J (2005) The role of natural antibodies in atherogenesis. J Lipid Res 46(7):1353–1363
Shaw P (2004) Rethinking oxidized low density lipoprotein, its role in atherosclerosis and the immune response associated with it. Arch Immunol Ther Exp 52:225–239
Binder C, Shaw P, Chang M, Booullier A, Hartvigsen K, Hörkkö S, Miller Y, Woelkers D, Corr M, Witztum J (2005) The role natural antibodies in atheroclerosis. J Lipid Research 46:1353–1363
Binder C, Silverman G (2005) Natural antibodies and the immunity of atherosclerosis. Springer Semin Immun 26:385–404
Tertov V, Sobenin I, Orekhov A, Jaakkola O, Solakivi T, Nnikkari T (1996) Characteristics of low density lipoprotein isolated from circulating immune complexes. Atherosclerosis 122(2):191–199
Wagner J, Cefal W, Anthony M, Litwak K, Zhang L, Clarkson T (1997) Dietary soy protein and estrogen replacement therapy improve cardiovascular risk factors and decrease aortic cholesterol ester content in ovariectomized cynomolgus monkeys. Metabolism 46(6): 698–705
Jenkins D, Kedall C, Garsetti M, Rosenberg-Zang R, Jackson C, Agarwal S, Diamandi E, Parkert R, Faulkner D, Vuksan V, Vidgen E (2000) Effect of soy protein foods on low-density lipoprotein oxidation and ex vivo sex hormone receptor activity – a controlled crossover trial. Metabolism 49(4):537–546
Wu J, Wang X, Chiba H, Higuchi M, Nakatani T, Ezaki O, Cui H, Yamada K, Ishimi Y (2004) Combined intervention of soy isoflavone and moderate exercise prevents body fat elevation and bone loss in ovariectomized mice. Metabolism 53(7):942–948
Manzoni MS, Rossi EA, Carlos IZ, Vendramini RC, Duarte AC, Damaso AR (2005) Fermented soy product supplemented with isoflavones affected fat depots in juvenile rats. Nutrition 21(10):1018–1024
Hertrampf T, Degen GH, Kaid AA, Laudenbach-Leschowsky U, Seibel J, Di Virgilio AL, Diel P (2006) Combined effects of physical activity, dietary isoflavones and 17beta-estradiol on movement drive, body weight and bone mineral density in ovariectomized female rats. Planta Medica 72(6):484–487
Weickert MO, Reimann M, Otto B, Hall WL, Vafeiadou K, Hallund J, Ferrari M, Talbot D, Branca F, Bugel S, Williams CM, Zunft HJ, Koebnick C (2006) Soy isoflavones increase preprandial peptide YY (PYY), but have no effect on ghrelin and body weight in healthy postmenopausal women. J Negat Results Biomed 5:11–14
Acknowledgments
This study was supported by FAPESP (grant 97/05090 to D.S.P.A. and scholarship 97/09686-8 to N. R. T. D.) and PRONEX. The authors thank Cleiton Alves for technical assistance and Bunge Alimentos S/A for donation of soy isoflavones.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Teixeira Damasceno, N.R., Apolinário, E., Dias Flauzino, F. et al. Soy isoflavones reduce electronegative low-density lipoprotein (LDL−) and anti-LDL− autoantibodies in experimental atherosclerosis. Eur J Nutr 46, 125–132 (2007). https://doi.org/10.1007/s00394-006-0640-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00394-006-0640-9